Paesmans M. Prognosis of small cell lung cancer. In: Sculier J-P, Fry WA (eds). Malignant tumors of the lung. Berlin, Springer-Verlag, 2004, p 423-432.Paesmans M (2004) Prognosis of small cell lung cancer. In: Sculier JP, Fray WA (eds) Malignant tumors of the lung. Springer,...
Small-cell lung cancer (SCLC) is a deadly cancer associated with smoke exposure that has neuroendocrine (NE) cell properties and is pathologically, molecularly, biologically and clinically very different from other lung cancers. While most patients with SCLC respond initially to cytotoxic therapy, almo...
Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival model The aim of our study was the comparative evaluation of a relative survival model and a Cox model to determine the prognostic factors of survival for patien... P Foucher,B Coudert,P Arveux,... - 《Eu...
Histologic transformation from NSCLC to small-cell lung cancer (SCLC), which arises in 4–15% of cases, is a known mechanism of resistance to first-generation EGFR-TKIs that dramatically impacts patients’ prognosis, and has been reported as an important cause of resistance to osimertinib.75,76...
Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study SMALL cell lung cancerPROGNOSISIMMUNOTHERAPYPROPENSITY score matchingPROGRESSION-free survivalSURVIVAL rateBackground: The utilization of the Gustave Roussy Immun...
Small cell lung cancer (SCLC) represents approximately 13% of all lung cancer diagnoses and the incidence has reduced over the last 20 years. Treatment of
AstraZeneca’sImfinzi(durvalumab) has been recommended for approval in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following platinum-based chemoradiation therapy (CRT). ...
Non-small cell lung cancer; postoperative follow-up; thoracic surgery; expert consensus DOI: 10.7507/1007-4848.202501057 Export PDF Favorites Scan Get Citation Shared Abstract Figures/Tables References Cited by Surgical treatment is one of the key approaches for non-small cell lung cancer (...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
Brain metastases represent an important clinical problem for patients with small-cell lung cancer (SCLC). However, the mechanisms underlying SCLC growth in the brain remain poorly understood. Here, using intracranial injections in mice and assembloids be